Dr. Surya has more than 30 years of research experience and has held leadership positions of increasing seniority in the industry. He founded Curadev along with his partner Manish Tandon in 2010. In less than a decade Curadev has emerged as one of India's rare drug discovery success stories with a slew of first in class small molecule patents that have emerged from its unique approach to target selection and drug discovery. Two of Curadev's lead drug candidates and programs have been licensed to Top 10 Big Pharma companies. He has extensive experience in the assessment of drug molecules against several target classes across a range of therapeutic areas and specializes in building high performance research teams. His past organizations include SmithKline Beecham, Ranbaxy and TCG Lifesciences where he played a founding role in establishing the biology and drug discovery teams. Dr. Surya has an integrated Masters in Physics from llT Kanpur and a PhD in Biophysics from Syracuse University.